Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
71,366,920
-
Total 13F shares
-
31,669,684
-
Share change
-
+5,574,548
-
Total reported value
-
$1,199,070,921
-
Price per share
-
$37.84
-
Number of holders
-
106
-
Value change
-
+$211,475,628
-
Number of buys
-
77
-
Number of sells
-
26
Institutional Holders of C4 Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CCCC) as of Q2 2021
As of 30 Jun 2021 C4 Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CCCC) had 106 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 31,669,684 shares of stock of the company.
Largest 10 holders included PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., PERCEPTIVE ADVISORS LLC, RTW INVESTMENTS, LP, Bain Capital Life Sciences Investors, LLC, VANGUARD GROUP INC, ArrowMark Colorado Holdings LLC, WASATCH ADVISORS INC, RA CAPITAL MANAGEMENT, L.P., and STATE STREET CORP.
This table shows 105 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.